RaQualia Pharma Inc. logo

RaQualia Pharma Inc.

TSE:4579.T

Overview | Financials
Company Name RaQualia Pharma Inc.
Symbol 4579.T
Currency JPY
Price 562
Market Cap 12,160,679,078
Dividend Yield 0%
52-week-range 479 - 943
Industry Biotechnology
Sector Healthcare
CEO Mr. Hirobumi Takeuchi
Website https://www.raqualia.co.jp

An error occurred while fetching data.

About RaQualia Pharma Inc.

RaQualia Pharma Inc. engages in the research and development of pharmaceutical compounds worldwide. Its human products portfolio includes tegoprazan for gastroesophageal reflux disease, which is in phase 1 clinical trial in the United States; and grapiprant for pain management, which is in phase II clinical trial in the United States

Related Stocks

ReproCELL Incorporated logo

ReproCELL Incorporated

4978.T

129 JPY

FINDEX Inc. logo

FINDEX Inc.

3649.T

881 JPY

NanoCarrier Co., Ltd. logo

NanoCarrier Co., Ltd.

4571.T

195 JPY

Astena Holdings Co., Ltd. logo

Astena Holdings Co., Ltd.

8095.T

514 JPY

Daiken Medical Co., Ltd. logo

Daiken Medical Co., Ltd.

7775.T

529 JPY

3-D Matrix, Ltd. logo

3-D Matrix, Ltd.

7777.T

119 JPY

JMS Co.,Ltd. logo

JMS Co.,Ltd.

7702.T

505 JPY

Medical System Network Co., Ltd. logo

Medical System Network Co., Ltd.

4350.T

440 JPY

Techno Medica Co., Ltd. logo

Techno Medica Co., Ltd.

6678.T

1,935 JPY

OncoTherapy Science, Inc. logo

OncoTherapy Science, Inc.

4564.T

40 JPY

Financials

Numbers are in millions USD

Numbers are in millions USD